J&J “Actively Engaged” Lobbying Against Obama Corporate Tax Provision
This article was originally published in The Pink Sheet Daily
Executive Summary
Repeal of deferral of corporate tax on foreign income is short-sighted, J&J says; company stays mum, though, on Remicade, golimumab negotiations with Merck.